CellaVision AB (publ)
CLVSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7 | $4 | $6 | $7 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7 | $4 | $6 | $7 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 6.8% | 5.9% | 13% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.3% | 68.4% | 68.6% | 69.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.4% | 30.6% | 29.9% | 34.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 19.5% | 19.2% | 18.5% | 22.2% |
| EPS Diluted | 5.9 | 5.46 | 4.96 | 5.25 |
| % Growth | 8.1% | 10.1% | -5.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |